or impaired concentration, a suicide attempt remeron drug suicidal ideation.The effectiveness of REMERON® in hospitalized depressed patients has not been adequately studied.The remeron drug of REMERON® in maintaining a response in patients with major depressive disorder for up to 40 remeron drug following remeron drug weeks remeron drug initial open-label treatment was.

months or longer of sustained pharmacological therapy beyond response to the acute episode. Systematic evaluation remeron drug REMERON® (mirtazapine) Tablets has demonstrated that its efficacy in major depressive remeron drug is maintained for periods of remeron drug to 40 weeks following 8–12 weeks of initial treatment at remeron drug dose of 15–45 mg/day (see CLINICAL remeron drug Based on these limited data, it is unknown whether or remeron drug the dose of REMERON® remeron drug for maintenance treatment is identical to the dose needed to achieve remeron drug initial remeron drug Patients should be periodically reassessed to determine the need for remeron drug treatment and the appropriate dose for such treatment.Switching Patients To or remeron drug a Monoamine Oxidase InhibitorAt least 14 days should elapse between discontinuation remeron drug an MAOI and initiation remeron drug therapy with REMERON® (mirtazapine) Tablets. remeron drug addition, at least 14 days should be allowed after remeron drug REMERON® before starting REMERON®.

disorder for REMERON® has not been adequately explored, patients not remeron drug to the initial remeron drug mg dose may benefit from dose.